Sarah Riley, MD
she/her/hers
Assistant Professor of PsychiatryDownloadHi-Res Photo
Cards
Appointments
Psychiatry
Primary
Additional Titles
Medical Director, Specialized Treatment Early in Psychosis (STEP) Program, Psychiatry
Contact Info
Specialized Treatment for Early Psychosis (STEP) Program
34 Park Street
New Haven, CT 06519
United States
Appointments
Psychiatry
Primary
Additional Titles
Medical Director, Specialized Treatment Early in Psychosis (STEP) Program, Psychiatry
Contact Info
Specialized Treatment for Early Psychosis (STEP) Program
34 Park Street
New Haven, CT 06519
United States
Appointments
Psychiatry
Primary
Additional Titles
Medical Director, Specialized Treatment Early in Psychosis (STEP) Program, Psychiatry
Contact Info
Specialized Treatment for Early Psychosis (STEP) Program
34 Park Street
New Haven, CT 06519
United States
About
Titles
Assistant Professor of Psychiatry
Medical Director, Specialized Treatment Early in Psychosis (STEP) Program, Psychiatry
Appointments
Psychiatry
Assistant ProfessorPrimary
Other Departments & Organizations
- Psychiatry
- Specialized Treatment for Early Psychosis (STEP) Program
- Yale Center for Asylum Medicine
- Yale Medicine
Education & Training
- Residency
- Yale University (2020)
- Chief Resident, Crisis Intervention Unit
- Yale New Haven Hospital (2020)
- Chief Resident, WS3 (Transitional Age Youth Unit)
- Yale Psychiatric Hospital (2019)
- MD
- University at Buffalo School of Medicine and Biomedical Sciences (2016)
- BS
- Boston College, Biology (2010)
Board Certifications
Psychiatry
- Certification Organization
- AB of Psychiatry & Neurology
- Latest Certification Date
- 2025
- Original Certification Date
- 2021
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Sarah Riley's published research.
Publications Timeline
A big-picture view of Sarah Riley's research output by year.
Fangyong Li, MS, MPH
Hadar Hazan, PhD
Vinod H. Srihari, MD
Cenk Tek, MD
Maria Ferrara, MD
Hun Millard, MD
10Publications
7Citations
Publications
2024
The anomalous effect of COVID-19 pandemic restrictions on the duration of untreated psychosis
Nicholls-Mindlin J, Hazan H, Zhou B, Li F, Ferrara M, Levine N, Riley S, Karmani S, Mathis W, Keshavan M, Srihari V. The anomalous effect of COVID-19 pandemic restrictions on the duration of untreated psychosis. BJPsych Open 2024, 10: e216. PMID: 39628123, DOI: 10.1192/bjo.2024.813.Peer-Reviewed Original ResearchThe Impact of Duration of Untreated Psychosis on Functioning and Quality of Life Over One Year of Coordinated Specialty Care (CSC)
Hazan H, Tayfur S, Zhou B, Li F, Gibbs-Dean T, Karmani S, Kline E, Ferrara M, Corbera S, Riley S, Cahill J, Tek C, Keshavan M, Srihari V. The Impact of Duration of Untreated Psychosis on Functioning and Quality of Life Over One Year of Coordinated Specialty Care (CSC): PLOS ONE, October 2024.Peer-Reviewed Original Research In PressThe Anomalous Effect of COVID-19 Pandemic Restrictions on the Duration of Untreated Psychosis (DUP).
Nicholls-Mindlin J, Hazan H, Zhou B, Li F, Ferrara M, Levine N, Riley S, Karmani S, Mathis WS, Keshavan MS, Srihari V. The Anomalous Effect of COVID-19 Pandemic Restrictions on the Duration of Untreated Psychosis (DUP). MedRxiv 2024 PMID: 38766117, DOI: 10.1101/2024.05.09.24306737.Peer-Reviewed Original ResearchThe impact of early detection (ED) campaigns on care presentations: Beyond DUP reduction
Hazan H, Ferrara M, Riley S, Li F, Zhou B, Kline E, Gibbs-Dean T, Karmani S, Tayfur S, Tek C, Keshavan M, Srihari V. The impact of early detection (ED) campaigns on care presentations: Beyond DUP reduction. Schizophrenia Research 2024, 264: 457-461. PMID: 38266513, PMCID: PMC10923115, DOI: 10.1016/j.schres.2024.01.022.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsCoordinated specialty careDuration of untreated psychosisImpact of early detectionEarly detectionEarly detection campaignsSpecialty careAdjustment scoresCampaign yearDetection campaignsMediation analysisEffects of EDRegression modelsCareUntreated psychosisPositive symptomsGAFPatientsSalutary effects
2023
The effect of duration of untreated psychosis (DUP) on the risk for hospitalization after admission to a first episode service
Ferrara M, Guloksuz S, Hazan H, Li F, Tek C, Sykes L, Riley S, Keshavan M, Srihari V. The effect of duration of untreated psychosis (DUP) on the risk for hospitalization after admission to a first episode service. Schizophrenia Research 2023, 260: 198-204. PMID: 37688984, DOI: 10.1016/j.schres.2023.08.005.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsFirst-episode psychosis servicesLength of stayUntreated psychosisPsychiatric hospitalizationFirst-episode servicesDuration of hospitalizationIncidence rate ratiosNon-affective psychosisNew Haven areaPoisson regression modelsPatient characteristicsHospitalization ratesRecent onsetMedical recordsHospitalizationEffect of durationNegative binomial regressionSpecialized treatmentPsychosisRate ratioBinomial regressionAdmissionDUPEnrollmentFirst yearA Novel Approach to Delivering Evidence-based, High-quality Care in Psychiatry Through an Electronic Integrated Care Pathway (eICP) Pilot
Li L, Kruger M, Kim N, Ong S, Riley S, Cameron K, Koslosky K, Rhodes D. A Novel Approach to Delivering Evidence-based, High-quality Care in Psychiatry Through an Electronic Integrated Care Pathway (eICP) Pilot. Psychiatric Quarterly 2023, 94: 103-111. PMID: 36840898, PMCID: PMC9959944, DOI: 10.1007/s11126-023-10016-z.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsElectronic health recordsUser-friendly experienceEvidence-based decision support toolUsage trackingDecision support toolSupport toolHealth recordsIntegrated care pathwayNovel approachService areaTeam structureImplementationEarly adoptionAdoptionTechnology columnHealth service areasAcademic medical centerQuality of careHigh-quality careTrackingAdoption resultsCare pathwayFuture directionsMedical CenterTechnology
2022
Methemoglobinemia in a Patient Presenting with an Undisclosed Intentional Overdose
Gibson C, Abdallah S, Neumann N, Millard H, Riley S. Methemoglobinemia in a Patient Presenting with an Undisclosed Intentional Overdose. Harvard Review Of Psychiatry 2022, 30: 361-368. PMID: 36534838, DOI: 10.1097/hrp.0000000000000348.Peer-Reviewed Case Reports and Technical NotesCitationsAltmetricFirst Episode Psychosis and Pituitary Hyperplasia in a Patient With Untreated Hashimoto’s Thyroiditis: A Case Report
Lipkes C, Haider S, Rashid A, Angarita GA, Riley S. First Episode Psychosis and Pituitary Hyperplasia in a Patient With Untreated Hashimoto’s Thyroiditis: A Case Report. Frontiers In Psychiatry 2022, 13: 863898. PMID: 35401262, PMCID: PMC8987109, DOI: 10.3389/fpsyt.2022.863898.Peer-Reviewed Case Reports and Technical NotesCitationsAltmetricConceptsHashimoto's thyroiditisCase reportThorough medical workupThyroid hormone replacementUntreated primary hypothyroidismNew-onset psychosisDuration of treatmentFirst-episode psychosisUntreated Hashimoto's thyroiditisPsychiatric emergency departmentInitial workupHormone replacementPrimary hypothyroidismOrganic causeEmergency departmentHigh thyroidMedical workupPituitary hyperplasiaEpisode psychosisFirst episodeOnset psychosisPsychiatric historyAdjunctive antipsychoticsThyroiditisPhysical symptoms
2013
A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN).
Limaye S, Riley S, Zhao S, O'Neill A, Posner M, Adkins D, Jaffa Z, Clark J, Haddad R. A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN). Oral Oncol 2013, 49: 835-41. PMID: 23727257, DOI: 10.1016/j.oraloncology.2013.04.010.Peer-Reviewed Original ResearchInduction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.
Haddad R, O'Neill A, Rabinowits G, Tishler R, Khuri F, Adkins D, Clark J, Sarlis N, Lorch J, Beitler JJ, Limaye S, Riley S, Posner M. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol 2013, 14: 257-64. PMID: 23414589, DOI: 10.1016/S1470-2045(13)70011-1.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
activity Society of Asylum Medicine
Professional OrganizationsMemberDetails10/17/2023 - Presentactivity American Association for Community Psychiatry
Professional OrganizationsMemberDetails11/08/2023 - Presentactivity Peer Review and Privileging Committee, Connecticut Mental Health Center
CommitteesMemberDetails2023 - Presentactivity Yale Center for Asylum Medicine
Public ServiceFaculty MemberDetails2023 - Presentactivity Safety Committee, Connecticut Mental Health Center
CommitteesMemberDetails2022 - 2023
News
News
- February 13, 2024Source: WNPR
Mindmap 2.0 on Connecticut Public Radio
- October 10, 2023
Riley Appointed Medical Director of STEP Clinic
- July 20, 2017
Yale Psychiatry Residents' Association elects new officers
Get In Touch
Contacts
Email
Mailing Address
Specialized Treatment for Early Psychosis (STEP) Program
34 Park Street
New Haven, CT 06519
United States